Regulatory roles of junctin in sarcoplasmic reticulum calcium cycling and myocardial function.

Junctin (JCN), a 26-kd sarcoplasmic reticulum (SR) transmembrane protein, forms a quaternary protein complex with the ryanodine receptor, calsequestrin, and triadin in the SR lumen of cardiac muscle. Within this complex, calsequestrin, triadin, and JCN appear to be critical for normal regulation of ryanodine receptor-mediated calcium (Ca) release. Junctin and triadin exhibit 60% to 70% amino acid homology in their transmembrane domains, including repeated KEKE motifs important for macromolecular protein-protein interactions within their SR luminal tails. Recent studies have uncovered functional roles of both JCN and triadin in the mouse heart, using transgenic overexpression strategies, which exhibit varying phenotypes including mild SR structural alterations, prolongation of Ca transient decay, impaired relaxation, and cardiac hypertrophy and/or heart failure. More specifically, both in vitro adenoviral gene transfer and in vivo gene-targeting techniques to manipulate JCN expression levels have shown that JCN is an essential factor in maintaining normal cardiac Ca handling and cardiac function. This article reviews the new findings on the regulatory roles of JCN in cardiac SR Ca cycling and contractility, with special emphasis on the effects of JCN ablation on delayed after depolarization-induced arrhythmias and premature mortality in mouse models.

[1]  H. Drexler,et al.  Reciprocal changes in the postnatal expression of the sarcolemmal Na+-Ca(2+)-exchanger and SERCA2 in rat heart. , 1995, Journal of molecular and cellular cardiology.

[2]  G. Fan,et al.  Junctin is a prominent regulator of contractility in cardiomyocytes. , 2007, Biochemical and biophysical research communications.

[3]  F. Müller,et al.  On the role of junctin in cardiac Ca2+ handling, contractility, and heart failure. , 2007, American journal of physiology. Heart and circulatory physiology.

[4]  L. Jones,et al.  Ca2+ binding effects on protein conformation and protein interactions of canine cardiac calsequestrin. , 1988, The Journal of biological chemistry.

[5]  C. Franzini-armstrong,et al.  Structural alterations in cardiac calcium release units resulting from overexpression of junctin. , 2001, Journal of molecular and cellular cardiology.

[6]  N. Neff,et al.  Absence of Post-translational Aspartyl β-Hydroxylation of Epidermal Growth Factor Domains in Mice Leads to Developmental Defects and an Increased Incidence of Intestinal Neoplasia* , 2002, The Journal of Biological Chemistry.

[7]  G. Dorn,et al.  Sarcoplasmic Reticulum Calcium Overloading in Junctin Deficiency Enhances Cardiac Contractility but Increases Ventricular Automaticity , 2007, Circulation.

[8]  Peter Lipp,et al.  Overexpression of junctin causes adaptive changes in cardiac myocyte Ca(2+) signaling. , 2006, Cell calcium.

[9]  J. Buecker,et al.  Development of Dyadic Junctional Complexes between Sarcoplasmic Reticulum and Plasmalemma in Rabbit Left Ventricular Myocardial Cells: Morphometric Analysis , 1981, Circulation research.

[10]  S. Priori,et al.  Abnormal Calcium Signaling and Sudden Cardiac Death Associated With Mutation of Calsequestrin , 2004, Circulation research.

[11]  W. Lederer,et al.  Calcium sparks and [Ca2+]i waves in cardiac myocytes. , 1996, The American journal of physiology.

[12]  G. Wetzel,et al.  Molecular cloning of junctin from human and developing rabbit heart. , 2000, Molecular genetics and metabolism.

[13]  D. Kim,et al.  cDNA cloning and characterization of human cardiac junctin. , 2000, Gene.

[14]  Impaired relaxation in transgenic mice overexpressing junctin. , 2003, Cardiovascular research.

[15]  V. Fuster,et al.  Sudden cardiac death: mechanisms, therapies and challenges , 2005, Nature Clinical Practice Cardiovascular Medicine.

[16]  D. H. Kim,et al.  The asp‐rich region at the carboxyl‐terminus of calsequestrin binds to Ca2+ and interacts with triadin , 2000, FEBS letters.

[17]  D. H. Kim,et al.  Molecular cloning and characterization of mouse cardiac junctate isoforms. , 2001, Biochemical and biophysical research communications.

[18]  Donald M. Bers,et al.  Upregulated Na/Ca exchange is involved in both contractile dysfunction and arrhythmogenesis in heart failure , 2002, Basic Research in Cardiology.

[19]  M. Cho,et al.  Cardiac remodeling and atrial fibrillation in transgenic miceoverexpressing junctin , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  K. O'Neil,et al.  Aspartyl β-Hydroxylase (Asph) and an Evolutionarily Conserved Isoform of Asph Missing the Catalytic Domain Share Exons with Junctin* , 2000, The Journal of Biological Chemistry.

[21]  S. Priori,et al.  Abnormal Interactions of Calsequestrin With the Ryanodine Receptor Calcium Release Channel Complex Linked to Exercise-Induced Sudden Cardiac Death , 2006, Circulation research.

[22]  E. Marbán,et al.  Mechanisms of arrhythmogenic delayed and early afterdepolarizations in ferret ventricular muscle. , 1986, The Journal of clinical investigation.

[23]  A. Moorman,et al.  Patterns of expression of sarcoplasmic reticulum Ca(2+)-ATPase and phospholamban mRNAs during rat heart development. , 1995, Circulation research.

[24]  Sandor Györke,et al.  The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium. , 2004, Biophysical journal.

[25]  Yvonne M. Kobayashi,et al.  Complex Formation between Junctin, Triadin, Calsequestrin, and the Ryanodine Receptor , 1997, The Journal of Biological Chemistry.

[26]  M. Lohse,et al.  Early impairment of calcium handling and altered expression of junctin in hearts of mice overexpressing the β1−adrenergic receptor , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  R. Gambari,et al.  Myocyte Enhancer Factor 2 Activates Promoter Sequences of the Human AβH-J-J Locus, Encoding Aspartyl-β-Hydroxylase, Junctin, and Junctate , 2005, Molecular and Cellular Biology.

[28]  R. Gambari,et al.  Molecular Cloning, Expression, Functional Characterization, Chromosomal Localization, and Gene Structure of Junctate, a Novel Integral Calcium Binding Protein of Sarco(endo)plasmic Reticulum Membrane* , 2000, The Journal of Biological Chemistry.

[29]  L. Jones,et al.  Purification, Primary Structure, and Immunological Characterization of the 26-kDa Calsequestrin Binding Protein (Junctin) from Cardiac Junctional Sarcoplasmic Reticulum (*) , 1995, The Journal of Biological Chemistry.

[30]  CharlesAntzelevitch,et al.  Cellular Mechanisms Underlying the Development of Catecholaminergic Ventricular Tachycardia , 2005 .

[31]  DaweiJiang,et al.  Enhanced Basal Activity of a Cardiac Ca2+ Release Channel (Ryanodine Receptor) Mutant Associated With Ventricular Tachycardia and Sudden Death , 2002 .

[32]  P. Kirchhof,et al.  Age-dependent biochemical and contractile properties in atrium of transgenic mice overexpressing junctin. , 2004, American journal of physiology. Heart and circulatory physiology.

[33]  C. Antzelevitch,et al.  Cellular Mechanisms Underlying the Development of Catecholaminergic Ventricular Tachycardia , 2005, Circulation.

[34]  S. Priori,et al.  Clinical Phenotype and Functional Characterization of CASQ2 Mutations Associated With Catecholaminergic Polymorphic Ventricular Tachycardia , 2006, Circulation.